VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by bullboardmonkeyon Jan 17, 2017 12:45pm

122 Views

Post# 25717878

RE:Complete Heart Analysis System Application - Health Canada

God Help me niner, but I added some this morning. They have, at least, proven that they were able to complete the technology without the presence of the members of the development team that left last year. Approval from Health Canada is very likely, and if they could actually sell a few units, we might generate some outside interest moving forward. I would assume that Skidmore has our financial back until then, as he owns considerable equity in the company.

Bullboard Posts

Three mispriced stocks exposed to major market tailwinds